Daptomycin-Induced Pulmonary Toxicity: A Case Series
Y. Patel, S. Natarajan, Srinivasarao Ramakrishna, Pius Ochieng
Abstract
Open-access reader
Y. Patel, S. Natarajan, Srinivasarao Ramakrishna, Pius Ochieng
Abstract
Open-access reader
Daptomycin is a bactericidal antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Eosinophilic pneumonia is an uncommon but significant adverse effect of daptomycin. We present two patients treated with daptomycin who subsequently developed eosinophilic pneumonia (EP).
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Daptomycin is a bactericidal antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Eosinophilic pneumonia is an uncommon but significant adverse effect of daptomycin. We present two patients treated with daptomycin who subsequently developed eosinophilic pneumonia (EP).
Key concepts: Daptomycin, Medicine, Eosinophilic pneumonia, Pneumonia, Staphylococcus aureus, Enterococcus, Vancomycin, Antibiotics